Medical Radiation Shielding Market by Products (Shields, Booths, Lead sheet, Doors, Windows, Curtain, X-Ray), Solution (Radiation Therapy, Cyclotron, PET, CT, MRI), End-user (Hospitals, Clinics, ASCs, Diagnostic Center), & Region - Global Forecast to 2028
The medical radiation shielding market is projected to reach USD 1.8 Billion by 2028 from USD 1.4 Billion in 2023, at a CAGR of 6.5% during the forecast period. Growth in MRI shielding products is mainly driven by the Awareness of the potential health risks associated with exposure to ionizing radiation is increasing rapidly among people working in radiation-prone environments. Various government and private organizations, such as Health Canada, the National Council on Radiation Protection & Measurements (NCRP), and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), have incorporated guidelines and protocols regarding radiation shielding products. These initiatives increase safety awareness among professionals and encourage the adoption of radiation protection systems. Conferences and symposia also showcase research in this field and make industry leaders aware of the developments in this sector.
“The Diagnostic Shielding segment accounted for the highest market share in the medical radiation shielding solution market, by type, during the forecast period.”
Based on the solution of the segment, the medical radiation shielding market is categorized as Diagnostic Shielding and Radiation Therapy Shielding. Diagnostic Shielding is expected to have the highest growth in the market, which is attributed to the rising prevalence of various chronic diseases like cancer, which is attributed to the Increasing public-private investments in cancer research, id supporting the growth of the Diagnostic Shielding market.
“The North America segment accounted for the highest market share in the medical radiation shielding market, by region, during the forecast period.”
Based on the region, the global medical radiation shielding market is categorized into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to witness a high market share during the forecast period due to the Increasing number of trained radiologic technologists. According to the Bureau of Labor Statistics, in 2020, ~254,000 radiologic technologists’ jobs were expected to be available in the US. The Bureau of Labor Statistics has also estimated that the employment of radiologic and MRI technologists is expected to grow at a rate of 9% from 2020 to 2030 in the US.
Breakdown of supply-side primary interviews by company type, designation, and region:
Research Coverage
This research report categorizes the medical radiation shielding market by product (MRI Shielding Products, Lead Lined Glass, Doors & Windows, Lead Lined Drywalls & Plywood, Shields, Barriers, Booths, Lead Sheet, Lead Bricks, High-Density Concrete Blocks, X-ray Rooms, Lead Curtains & Screens and Lead Acrylic), By Solution (Diagnostic Shielding and Radiation Therapy Shielding), Diagnostic Shielding segment (X-ray, MRI, CT scanners and Nuclear Imaging) and Radiation Therapy Shielding segment (Linear Accelerator, Multimodality, Cyclotron, Brachytherapy, and Proton Therapy), by end-user (Hospitals, Clinics and Ambulatory Surgery Centers and Diagnostic Centers), and region (North America, Europe, Asia Pacific and Rest of world). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the medical radiation shielding market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the medical radiation shielding market. Competitive analysis of upcoming startups in the medical radiation shielding market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical radiation shielding market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“The Diagnostic Shielding segment accounted for the highest market share in the medical radiation shielding solution market, by type, during the forecast period.”
Based on the solution of the segment, the medical radiation shielding market is categorized as Diagnostic Shielding and Radiation Therapy Shielding. Diagnostic Shielding is expected to have the highest growth in the market, which is attributed to the rising prevalence of various chronic diseases like cancer, which is attributed to the Increasing public-private investments in cancer research, id supporting the growth of the Diagnostic Shielding market.
“The North America segment accounted for the highest market share in the medical radiation shielding market, by region, during the forecast period.”
Based on the region, the global medical radiation shielding market is categorized into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to witness a high market share during the forecast period due to the Increasing number of trained radiologic technologists. According to the Bureau of Labor Statistics, in 2020, ~254,000 radiologic technologists’ jobs were expected to be available in the US. The Bureau of Labor Statistics has also estimated that the employment of radiologic and MRI technologists is expected to grow at a rate of 9% from 2020 to 2030 in the US.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (32%), Tier 2 (46%), and Tier 3 (22%)
- By Designation: C-level (40%), Director-level (26%), and Others (34%)
- By Region: North America (35%), Europe (30%), Asia- Pacific (21%), RoW- (14%),
Research Coverage
This research report categorizes the medical radiation shielding market by product (MRI Shielding Products, Lead Lined Glass, Doors & Windows, Lead Lined Drywalls & Plywood, Shields, Barriers, Booths, Lead Sheet, Lead Bricks, High-Density Concrete Blocks, X-ray Rooms, Lead Curtains & Screens and Lead Acrylic), By Solution (Diagnostic Shielding and Radiation Therapy Shielding), Diagnostic Shielding segment (X-ray, MRI, CT scanners and Nuclear Imaging) and Radiation Therapy Shielding segment (Linear Accelerator, Multimodality, Cyclotron, Brachytherapy, and Proton Therapy), by end-user (Hospitals, Clinics and Ambulatory Surgery Centers and Diagnostic Centers), and region (North America, Europe, Asia Pacific and Rest of world). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the medical radiation shielding market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the medical radiation shielding market. Competitive analysis of upcoming startups in the medical radiation shielding market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical radiation shielding market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, Growing incidences of cancer, Increasing safety awareness among people working in radiation-prone environments, Growth in the number of PET/CT scans, and Increasing number of trained radiologic technologists,), restraints (Lack of adequate healthcare infrastructure and Dearth Of Skilled Oncologist/Radiologist) opportunities (Rising healthcare expenditure across developing countries, Increasing public-private investments in cancer research, Growing government and private investments to meet the increasing demand for cancer treatment, Technological advancements in radiation detection and Increasing usage of nuclear medicine & radiation therapy coupled with the rising incidence of cancer) and Challenges (High cost of lead in manufacturing radiation accessories) are influencing the growth of the radiation shielding market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical radiation shielding market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the medical radiation shielding market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical radiation shielding market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, among others, in the medical radiation shielding market strategies.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 MEDICAL RADIATION SHIELDING MARKET SEGMENTATION
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
2.2.1 GROWTH FORECAST
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS
2.6 INDICATORS AND ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT
2.8 IMPACT OF RECESSION: MEDICAL RADIATION SHIELDING MARKET
3 EXECUTIVE SUMMARY
FIGURE 9 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 10 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2023 VS. 2028 (USD MILLION)
FIGURE 11 MEDICAL RADIATION SHIELDING MARKET FOR RADIATION THERAPY SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MEDICAL RADIATION SHIELDING MARKET
4 PREMIUM INSIGHTS
4.1 MEDICAL RADIATION SHIELDING MARKET OVERVIEW
FIGURE 15 GROWING GLOBAL INCIDENCE OF CANCER TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION AND COUNTRY, 2022
FIGURE 16 DIAGNOSTIC SHIELDING HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
4.3 MEDICAL RADIATION SHIELDING MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 17 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 MEDICAL RADIATION SHIELDING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing use of nuclear medicine and radiation therapy for diagnosis and treatment
5.2.1.2 Growing incidence of cancer
TABLE 2 NUMBER OF NEW CANCER CASES, 2020–2040
TABLE 3 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
5.2.1.3 Increasing safety awareness among people working in radiation-prone environments
5.2.1.4 Growth in number of PET/CT scans
TABLE 4 CT SCANNERS INSTALLED, BY COUNTRY, 2019 VS. 2021 (PER MILLION INHABITANTS)
TABLE 5 CT SCAN PROCEDURAL VOLUME, BY COUNTRY, 2019 VS. 2021 (PER 1,000 INHABITANTS)
5.2.1.5 Increasing number of trained radiologic technologists
TABLE 6 METROPOLITAN AREAS IN US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS
5.2.2 RESTRAINTS
5.2.2.1 Lack of adequate healthcare infrastructure
5.2.2.2 Shortage of skilled oncologists/radiologists
5.2.3 OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across developing countries
5.2.3.2 Increasing public-private investments in cancer research
5.2.3.3 Technological advancements in radiation detection
5.2.4 CHALLENGES
5.2.4.1 High cost of lead in manufacturing radiation accessories
5.3 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 20 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.5 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 BARGAINING POWER OF SUPPLIERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 KEY STAKEHOLDERS & BUYING CRITERIA
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)
5.6.2 BUYING CRITERIA
FIGURE 22 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
TABLE 8 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
5.7 REGULATORY LANDSCAPE
5.7.1 NORTH AMERICA
5.7.2 EUROPE
5.7.3 ASIA PACIFIC
5.8 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 10 EXPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)
5.9 ECOSYSTEM ANALYSIS
FIGURE 23 KEY PLAYERS OPERATING IN MEDICAL RADIATION SHIELDING MARKET
TABLE 11 ROLE IN ECOSYSTEM
5.10 PATENT ANALYSIS
5.11 KEY CONFERENCES & EVENTS IN 2023–2024
TABLE 12 LIST OF CONFERENCES & EVENTS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE OF KEY PRODUCTS
TABLE 13 PRICE RANGE OF KEY PRODUCTS IN MEDICAL RADIATION SHIELDING MARKET (USD)
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14 TECHNOLOGY ANALYSIS
6 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 14 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 MRI SHIELDING PRODUCTS
6.2.1 INCREASING INSTALLATION BASE OF MRI SCANNERS WORLDWIDE TO BOOST MARKET
TABLE 15 MEDICAL RADIATION SHIELDING MARKET FOR MRI SHIELDING PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
6.3 LEAD-LINED GLASS, DOORS, AND WINDOWS
6.3.1 ABILITY OF LEAD-LINED GLASS TO PROTECT PERSONNEL FROM UNNECESSARY RADIATION EXPOSURE TO PROPEL GROWTH
TABLE 16 MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED GLASS, DOORS, AND WINDOWS, BY REGION, 2021–2028 (USD MILLION)
6.4 LEAD-LINED DRYWALLS & PLYWOOD
6.4.1 GROWING DEMAND FOR LEAD-LINED PLYWOOD FOR HEAVIER LEAD SHIELDING REQUIREMENTS TO BOOST MARKET
TABLE 17 MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED DRYWALLS & PLYWOOD, BY REGION, 2021–2028 (USD MILLION)
6.5 SHIELDS, BARRIERS, AND BOOTHS
6.5.1 INCREASING NUMBER OF DIAGNOSTIC IMAGING CENTERS TO DRIVE GROWTH
TABLE 18 MEDICAL RADIATION SHIELDING MARKET FOR SHIELDS, BARRIERS, AND BOOTHS, BY REGION, 2021–2028 (USD MILLION)
6.6 LEAD SHEETS
6.6.1 CORROSION RESISTANCE ASSOCIATED WITH LEAD SHEETS TO FUEL DEMAND
TABLE 19 MEDICAL RADIATION SHIELDING MARKET FOR LEAD SHEETS, BY REGION, 2021–2028 (USD MILLION)
6.7 LEAD BRICKS
6.7.1 RESISTANCE TO DAMAGE TO DRIVE ADOPTION OF LEAD BRICKS
TABLE 20 MEDICAL RADIATION SHIELDING MARKET FOR LEAD BRICKS, BY REGION, 2021–2028 (USD MILLION)
6.8 HIGH-DENSITY CONCRETE BLOCKS
6.8.1 SIGNIFICANT ATTENUATION PROVIDED BY HIGH-DENSITY CONCRETE BLOCKS TO BOOST DEMAND
TABLE 21 MEDICAL RADIATION SHIELDING MARKET FOR HIGH-DENSITY CONCRETE BLOCKS, BY REGION, 2021–2028 (USD MILLION)
6.9 X-RAY ROOMS
6.9.1 DEVELOPMENT OF NEW MATERIALS AS ALTERNATIVES TO LEAD TO CREATE GROWTH OPPORTUNITIES
TABLE 22 MEDICAL RADIATION SHIELDING MARKET FOR X-RAY ROOMS, BY REGION, 2021–2028 (USD MILLION)
6.10 LEAD CURTAINS & SCREENS
6.10.1 GREATER SHIELDING CAPABILITY OF THICK LEAD SCREENS TO FAVOR MARKET GROWTH
TABLE 23 MEDICAL RADIATION SHIELDING MARKET FOR LEAD CURTAINS & SCREENS, BY REGION, 2021–2028 (USD MILLION)
6.11 LEAD ACRYLIC
6.11.1 SUPERIOR VISUAL CLARITY AND HIGH LIGHT TRANSMISSION OF LEAD ACRYLIC TO FUEL ADOPTION
TABLE 24 MEDICAL RADIATION SHIELDING MARKET FOR LEAD ACRYLIC, BY REGION, 2021–2028 (USD MILLION)
7 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION
7.1 INTRODUCTION
TABLE 25 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
7.2 RADIATION THERAPY SHIELDING
TABLE 26 RADIATION THERAPY SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 27 RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
7.2.1 LINEAR ACCELERATORS
7.2.1.1 Growing adoption of linear accelerators to drive market growth
TABLE 28 MEDICAL RADIATION SHIELDING MARKET FOR LINEAR ACCELERATORS, BY REGION, 2021–2028 (USD MILLION)
7.2.2 MULTIMODALITY IMAGING
7.2.2.1 Recent advances in multimodality imaging to boost market
TABLE 29 MEDICAL RADIATION SHIELDING MARKET FOR MULTIMODALITY IMAGING, BY REGION, 2021–2028 (USD MILLION)
7.2.3 CYCLOTRONS
7.2.3.1 Ability of cyclotrons to produce high yields of short half-life, neutron-deficient radioisotopes to favor market growth
TABLE 30 MEDICAL RADIATION SHIELDING MARKET FOR CYCLOTRONS, BY REGION, 2021–2028 (USD MILLION)
7.2.4 BRACHYTHERAPY
7.2.4.1 Ability of brachytherapy to deliver low-dose radiation to drive market
TABLE 31 MEDICAL RADIATION SHIELDING MARKET FOR BRACHYTHERAPY, BY REGION, 2021–2028 (USD MILLION)
7.2.5 PROTON THERAPY
7.2.5.1 Non-invasive and non-threatening nature of proton therapy to fuel adoption
TABLE 32 MEDICAL RADIATION SHIELDING MARKET FOR PROTON THERAPY, BY REGION, 2021–2028 (USD MILLION)
7.3 DIAGNOSTIC SHIELDING
TABLE 33 DIAGNOSTIC SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
7.3.1 CT SCANNERS
7.3.1.1 Rising demand for CT systems from hospitals, clinics, and ASCs to drive market
TABLE 35 MEDICAL RADIATION SHIELDING MARKET FOR CT SCANNERS, BY REGION, 2021–2028 (USD MILLION)
7.3.2 X-RAY IMAGING
7.3.2.1 Consistent high quality of images provided by digital imaging to boost demand
TABLE 36 MEDICAL RADIATION SHIELDING MARKET FOR X-RAY IMAGING, BY REGION, 2021–2028 (USD MILLION)
7.3.3 MRI
7.3.3.1 Wide use of MRI in hospitals for medical diagnosis and staging of diseases to boost growth
TABLE 37 MEDICAL RADIATION SHIELDING MARKET FOR MRI, BY REGION, 2021–2028 (USD MILLION)
7.3.4 NUCLEAR IMAGING
7.3.4.1 Recent advances in nuclear medicine to increase number of nuclear medicine procedures globally
TABLE 38 MEDICAL RADIATION SHIELDING MARKET FOR NUCLEAR MEDICINE, BY REGION, 2021–2028 (USD MILLION)
8 MEDICAL RADIATION SHIELDING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 39 MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS, ASCS, AND CLINICS
8.2.1 INCREASING NUMBER OF INTERNAL RADIATION THERAPY PROCEDURES TO BOOST MARKET GROWTH
TABLE 40 MEDICAL RADIATION SHIELDING MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC CENTERS
8.3.1 GROWING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE GROWTH
TABLE 41 MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
9 MEDICAL RADIATION SHIELDING MARKET, BY REGION
9.1 INTRODUCTION
TABLE 42 MEDICAL RADIATION SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 24 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT
TABLE 43 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 45 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American medical radiation shielding market during forecast period
TABLE 49 US: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 50 US: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 51 US: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 52 US: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 53 US: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Increasing number of radiography procedures to support market growth in Canada
TABLE 54 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 55 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 56 CANADA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 57 CANADA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 58 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 59 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Growing geriatric population and increasing radiography procedures in Germany to favor market growth
TABLE 65 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 66 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 67 GERMANY: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 68 GERMANY: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Large number of CT procedures performed to fuel market
TABLE 70 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 71 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 72 FRANCE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 73 FRANCE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 UK
9.3.4.1 Increasing government initiatives and support to aid market
TABLE 75 UK: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 76 UK: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 77 UK: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 78 UK: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 UK: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 REST OF EUROPE
TABLE 80 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 81 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 82 REST OF EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 REST OF EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 25 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT
TABLE 85 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Large patient pool and rising healthcare spending to aid market
TABLE 91 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 92 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 93 CHINA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 94 CHINA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 Rising awareness about radiation exposure to drive market
TABLE 96 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 97 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 98 JAPAN: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 99 JAPAN: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Favorable government policies and healthcare infrastructure to support market
TABLE 101 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 102 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 103 INDIA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 INDIA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 106 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC, 2020 VS. 2040
TABLE 107 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 108 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 109 REST OF ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 REST OF ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 REST OF THE WORLD (ROW)
9.5.1 REST OF THE WORLD (ROW): RECESSION IMPACT
TABLE 112 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 113 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 114 REST OF THE WORLD: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 REST OF THE WORLD: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
TABLE 117 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL RADIATION SHIELDING MARKET
10.2 MARKET RANKING
TABLE 118 TOP 3 COMPANIES IN MEDICAL RADIATION SHIELDING MARKET
10.3 COMPANY EVALUATION QUADRANT FOR TOP PLAYERS
10.3.1 STARS
10.3.2 EMERGING LEADERS
10.3.3 PARTICIPANTS
10.3.4 PERVASIVE PLAYERS
FIGURE 26 MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022
10.4 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
10.4.1 PROGRESSIVE COMPANIES
10.4.2 STARTING BLOCKS
10.4.3 RESPONSIVE COMPANIES
10.4.4 DYNAMIC COMPANIES
FIGURE 27 MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022
10.5 COMPETITIVE BENCHMARKING
TABLE 119 MEDICAL RADIATION SHIELDING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
10.6 COMPANY FOOTPRINT ANALYSIS
TABLE 120 FOOTPRINT ANALYSIS OF COMPANIES
TABLE 121 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
TABLE 122 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
10.7 COMPETITIVE SCENARIO
10.7.1 DEALS
TABLE 123 KEY DEALS, JANUARY 2020–MAY 2023
10.7.2 OTHER DEVELOPMENTS
TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020–MAY 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY)
TABLE 125 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): BUSINESS OVERVIEW
FIGURE 28 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): COMPANY SNAPSHOT (2022)
11.1.2 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.)
TABLE 126 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): BUSINESS OVERVIEW
FIGURE 29 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): COMPANY SNAPSHOT (2022)
11.1.3 NELCO WORLDWIDE
TABLE 127 NELCO WORLDWIDE: BUSINESS OVERVIEW
11.1.4 GAVEN INDUSTRIES, INC.
TABLE 128 GAVEN INDUSTRIES, INC.: BUSINESS OVERVIEW
11.1.5 RADIATION PROTECTION PRODUCTS, INC.
TABLE 129 RADIATION PROTECTION PRODUCTS, INC.: BUSINESS OVERVIEW
11.1.6 MARSHIELD (A DIVISION OF MARS METAL CO.)
TABLE 130 MARSHIELD (A DIVISION OF MARS METAL CO.): BUSINESS OVERVIEW
11.1.7 RAY-BAR ENGINEERING CORP.
TABLE 131 RAY-BAR ENGINEERING CORP.: BUSINESS OVERVIEW
11.1.8 AMRAY MEDICAL
TABLE 132 AMRAY MEDICAL: BUSINESS OVERVIEW
11.1.9 A&L SHIELDING
TABLE 133 A&L SHIELDING: BUSINESS OVERVIEW
11.1.10 GLOBAL PARTNERS IN SHIELDING, INC.
TABLE 134 GLOBAL PARTNERS IN SHIELDING, INC.: BUSINESS OVERVIEW
11.1.11 VERITAS MEDICAL SOLUTIONS LLC
TABLE 135 VERITAS MEDICAL SOLUTIONS, LLC: BUSINESS OVERVIEW
11.1.12 ALIMED, INC.
TABLE 136 ALIMED, INC.: BUSINESS OVERVIEW
11.1.13 PROTECH MEDICAL
TABLE 137 PROTECH MEDICAL: BUSINESS OVERVIEW
11.1.14 GLOBE COMPOSITE SOLUTIONS LLC
TABLE 138 GLOBE COMPOSITE SOLUTIONS LLC: BUSINESS OVERVIEW
11.1.15 ULTRARAY
TABLE 139 ULTRARAY: BUSINESS OVERVIEW
11.1.16 MARS METAL COMPANY
TABLE 140 MARS METAL COMPANY: BUSINESS OVERVIEW
11.1.17 NUCLEAR LEAD CO.
TABLE 141 NUCLEAR LEAD CO.: BUSINESS OVERVIEW
11.1.18 NUCLEAR SHIELDS B.V.
TABLE 142 NUCLEAR SHIELDS B.V.: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 SHIELDING INTERNATIONAL INC.
11.2.2 BAR-RAY PRODUCTS, INC.
11.2.3 XENA SHIELD
11.2.4 BURLINGTON MEDICAL
11.2.5 SIMAD SRL
11.2.6 EUROPEAN EMC PRODUCTS
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 MEDICAL RADIATION SHIELDING MARKET SEGMENTATION
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
2.2.1 GROWTH FORECAST
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS
2.6 INDICATORS AND ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT
2.8 IMPACT OF RECESSION: MEDICAL RADIATION SHIELDING MARKET
3 EXECUTIVE SUMMARY
FIGURE 9 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 10 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2023 VS. 2028 (USD MILLION)
FIGURE 11 MEDICAL RADIATION SHIELDING MARKET FOR RADIATION THERAPY SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MEDICAL RADIATION SHIELDING MARKET
4 PREMIUM INSIGHTS
4.1 MEDICAL RADIATION SHIELDING MARKET OVERVIEW
FIGURE 15 GROWING GLOBAL INCIDENCE OF CANCER TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION AND COUNTRY, 2022
FIGURE 16 DIAGNOSTIC SHIELDING HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
4.3 MEDICAL RADIATION SHIELDING MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 17 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 MEDICAL RADIATION SHIELDING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing use of nuclear medicine and radiation therapy for diagnosis and treatment
5.2.1.2 Growing incidence of cancer
TABLE 2 NUMBER OF NEW CANCER CASES, 2020–2040
TABLE 3 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
5.2.1.3 Increasing safety awareness among people working in radiation-prone environments
5.2.1.4 Growth in number of PET/CT scans
TABLE 4 CT SCANNERS INSTALLED, BY COUNTRY, 2019 VS. 2021 (PER MILLION INHABITANTS)
TABLE 5 CT SCAN PROCEDURAL VOLUME, BY COUNTRY, 2019 VS. 2021 (PER 1,000 INHABITANTS)
5.2.1.5 Increasing number of trained radiologic technologists
TABLE 6 METROPOLITAN AREAS IN US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS
5.2.2 RESTRAINTS
5.2.2.1 Lack of adequate healthcare infrastructure
5.2.2.2 Shortage of skilled oncologists/radiologists
5.2.3 OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across developing countries
5.2.3.2 Increasing public-private investments in cancer research
5.2.3.3 Technological advancements in radiation detection
5.2.4 CHALLENGES
5.2.4.1 High cost of lead in manufacturing radiation accessories
5.3 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 20 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.5 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 BARGAINING POWER OF SUPPLIERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 KEY STAKEHOLDERS & BUYING CRITERIA
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)
5.6.2 BUYING CRITERIA
FIGURE 22 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
TABLE 8 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
5.7 REGULATORY LANDSCAPE
5.7.1 NORTH AMERICA
5.7.2 EUROPE
5.7.3 ASIA PACIFIC
5.8 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 10 EXPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)
5.9 ECOSYSTEM ANALYSIS
FIGURE 23 KEY PLAYERS OPERATING IN MEDICAL RADIATION SHIELDING MARKET
TABLE 11 ROLE IN ECOSYSTEM
5.10 PATENT ANALYSIS
5.11 KEY CONFERENCES & EVENTS IN 2023–2024
TABLE 12 LIST OF CONFERENCES & EVENTS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE OF KEY PRODUCTS
TABLE 13 PRICE RANGE OF KEY PRODUCTS IN MEDICAL RADIATION SHIELDING MARKET (USD)
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14 TECHNOLOGY ANALYSIS
6 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 14 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 MRI SHIELDING PRODUCTS
6.2.1 INCREASING INSTALLATION BASE OF MRI SCANNERS WORLDWIDE TO BOOST MARKET
TABLE 15 MEDICAL RADIATION SHIELDING MARKET FOR MRI SHIELDING PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
6.3 LEAD-LINED GLASS, DOORS, AND WINDOWS
6.3.1 ABILITY OF LEAD-LINED GLASS TO PROTECT PERSONNEL FROM UNNECESSARY RADIATION EXPOSURE TO PROPEL GROWTH
TABLE 16 MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED GLASS, DOORS, AND WINDOWS, BY REGION, 2021–2028 (USD MILLION)
6.4 LEAD-LINED DRYWALLS & PLYWOOD
6.4.1 GROWING DEMAND FOR LEAD-LINED PLYWOOD FOR HEAVIER LEAD SHIELDING REQUIREMENTS TO BOOST MARKET
TABLE 17 MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED DRYWALLS & PLYWOOD, BY REGION, 2021–2028 (USD MILLION)
6.5 SHIELDS, BARRIERS, AND BOOTHS
6.5.1 INCREASING NUMBER OF DIAGNOSTIC IMAGING CENTERS TO DRIVE GROWTH
TABLE 18 MEDICAL RADIATION SHIELDING MARKET FOR SHIELDS, BARRIERS, AND BOOTHS, BY REGION, 2021–2028 (USD MILLION)
6.6 LEAD SHEETS
6.6.1 CORROSION RESISTANCE ASSOCIATED WITH LEAD SHEETS TO FUEL DEMAND
TABLE 19 MEDICAL RADIATION SHIELDING MARKET FOR LEAD SHEETS, BY REGION, 2021–2028 (USD MILLION)
6.7 LEAD BRICKS
6.7.1 RESISTANCE TO DAMAGE TO DRIVE ADOPTION OF LEAD BRICKS
TABLE 20 MEDICAL RADIATION SHIELDING MARKET FOR LEAD BRICKS, BY REGION, 2021–2028 (USD MILLION)
6.8 HIGH-DENSITY CONCRETE BLOCKS
6.8.1 SIGNIFICANT ATTENUATION PROVIDED BY HIGH-DENSITY CONCRETE BLOCKS TO BOOST DEMAND
TABLE 21 MEDICAL RADIATION SHIELDING MARKET FOR HIGH-DENSITY CONCRETE BLOCKS, BY REGION, 2021–2028 (USD MILLION)
6.9 X-RAY ROOMS
6.9.1 DEVELOPMENT OF NEW MATERIALS AS ALTERNATIVES TO LEAD TO CREATE GROWTH OPPORTUNITIES
TABLE 22 MEDICAL RADIATION SHIELDING MARKET FOR X-RAY ROOMS, BY REGION, 2021–2028 (USD MILLION)
6.10 LEAD CURTAINS & SCREENS
6.10.1 GREATER SHIELDING CAPABILITY OF THICK LEAD SCREENS TO FAVOR MARKET GROWTH
TABLE 23 MEDICAL RADIATION SHIELDING MARKET FOR LEAD CURTAINS & SCREENS, BY REGION, 2021–2028 (USD MILLION)
6.11 LEAD ACRYLIC
6.11.1 SUPERIOR VISUAL CLARITY AND HIGH LIGHT TRANSMISSION OF LEAD ACRYLIC TO FUEL ADOPTION
TABLE 24 MEDICAL RADIATION SHIELDING MARKET FOR LEAD ACRYLIC, BY REGION, 2021–2028 (USD MILLION)
7 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION
7.1 INTRODUCTION
TABLE 25 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
7.2 RADIATION THERAPY SHIELDING
TABLE 26 RADIATION THERAPY SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 27 RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
7.2.1 LINEAR ACCELERATORS
7.2.1.1 Growing adoption of linear accelerators to drive market growth
TABLE 28 MEDICAL RADIATION SHIELDING MARKET FOR LINEAR ACCELERATORS, BY REGION, 2021–2028 (USD MILLION)
7.2.2 MULTIMODALITY IMAGING
7.2.2.1 Recent advances in multimodality imaging to boost market
TABLE 29 MEDICAL RADIATION SHIELDING MARKET FOR MULTIMODALITY IMAGING, BY REGION, 2021–2028 (USD MILLION)
7.2.3 CYCLOTRONS
7.2.3.1 Ability of cyclotrons to produce high yields of short half-life, neutron-deficient radioisotopes to favor market growth
TABLE 30 MEDICAL RADIATION SHIELDING MARKET FOR CYCLOTRONS, BY REGION, 2021–2028 (USD MILLION)
7.2.4 BRACHYTHERAPY
7.2.4.1 Ability of brachytherapy to deliver low-dose radiation to drive market
TABLE 31 MEDICAL RADIATION SHIELDING MARKET FOR BRACHYTHERAPY, BY REGION, 2021–2028 (USD MILLION)
7.2.5 PROTON THERAPY
7.2.5.1 Non-invasive and non-threatening nature of proton therapy to fuel adoption
TABLE 32 MEDICAL RADIATION SHIELDING MARKET FOR PROTON THERAPY, BY REGION, 2021–2028 (USD MILLION)
7.3 DIAGNOSTIC SHIELDING
TABLE 33 DIAGNOSTIC SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
7.3.1 CT SCANNERS
7.3.1.1 Rising demand for CT systems from hospitals, clinics, and ASCs to drive market
TABLE 35 MEDICAL RADIATION SHIELDING MARKET FOR CT SCANNERS, BY REGION, 2021–2028 (USD MILLION)
7.3.2 X-RAY IMAGING
7.3.2.1 Consistent high quality of images provided by digital imaging to boost demand
TABLE 36 MEDICAL RADIATION SHIELDING MARKET FOR X-RAY IMAGING, BY REGION, 2021–2028 (USD MILLION)
7.3.3 MRI
7.3.3.1 Wide use of MRI in hospitals for medical diagnosis and staging of diseases to boost growth
TABLE 37 MEDICAL RADIATION SHIELDING MARKET FOR MRI, BY REGION, 2021–2028 (USD MILLION)
7.3.4 NUCLEAR IMAGING
7.3.4.1 Recent advances in nuclear medicine to increase number of nuclear medicine procedures globally
TABLE 38 MEDICAL RADIATION SHIELDING MARKET FOR NUCLEAR MEDICINE, BY REGION, 2021–2028 (USD MILLION)
8 MEDICAL RADIATION SHIELDING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 39 MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS, ASCS, AND CLINICS
8.2.1 INCREASING NUMBER OF INTERNAL RADIATION THERAPY PROCEDURES TO BOOST MARKET GROWTH
TABLE 40 MEDICAL RADIATION SHIELDING MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC CENTERS
8.3.1 GROWING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE GROWTH
TABLE 41 MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
9 MEDICAL RADIATION SHIELDING MARKET, BY REGION
9.1 INTRODUCTION
TABLE 42 MEDICAL RADIATION SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 24 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT
TABLE 43 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 45 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American medical radiation shielding market during forecast period
TABLE 49 US: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 50 US: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 51 US: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 52 US: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 53 US: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Increasing number of radiography procedures to support market growth in Canada
TABLE 54 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 55 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 56 CANADA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 57 CANADA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 58 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 59 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Growing geriatric population and increasing radiography procedures in Germany to favor market growth
TABLE 65 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 66 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 67 GERMANY: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 68 GERMANY: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Large number of CT procedures performed to fuel market
TABLE 70 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 71 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 72 FRANCE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 73 FRANCE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 UK
9.3.4.1 Increasing government initiatives and support to aid market
TABLE 75 UK: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 76 UK: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 77 UK: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 78 UK: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 UK: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 REST OF EUROPE
TABLE 80 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 81 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 82 REST OF EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 REST OF EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 25 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT
TABLE 85 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Large patient pool and rising healthcare spending to aid market
TABLE 91 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 92 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 93 CHINA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 94 CHINA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 Rising awareness about radiation exposure to drive market
TABLE 96 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 97 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 98 JAPAN: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 99 JAPAN: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Favorable government policies and healthcare infrastructure to support market
TABLE 101 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 102 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 103 INDIA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 INDIA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 106 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC, 2020 VS. 2040
TABLE 107 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 108 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 109 REST OF ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 REST OF ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 REST OF THE WORLD (ROW)
9.5.1 REST OF THE WORLD (ROW): RECESSION IMPACT
TABLE 112 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 113 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)
TABLE 114 REST OF THE WORLD: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 REST OF THE WORLD: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
TABLE 117 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL RADIATION SHIELDING MARKET
10.2 MARKET RANKING
TABLE 118 TOP 3 COMPANIES IN MEDICAL RADIATION SHIELDING MARKET
10.3 COMPANY EVALUATION QUADRANT FOR TOP PLAYERS
10.3.1 STARS
10.3.2 EMERGING LEADERS
10.3.3 PARTICIPANTS
10.3.4 PERVASIVE PLAYERS
FIGURE 26 MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022
10.4 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
10.4.1 PROGRESSIVE COMPANIES
10.4.2 STARTING BLOCKS
10.4.3 RESPONSIVE COMPANIES
10.4.4 DYNAMIC COMPANIES
FIGURE 27 MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022
10.5 COMPETITIVE BENCHMARKING
TABLE 119 MEDICAL RADIATION SHIELDING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
10.6 COMPANY FOOTPRINT ANALYSIS
TABLE 120 FOOTPRINT ANALYSIS OF COMPANIES
TABLE 121 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
TABLE 122 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
10.7 COMPETITIVE SCENARIO
10.7.1 DEALS
TABLE 123 KEY DEALS, JANUARY 2020–MAY 2023
10.7.2 OTHER DEVELOPMENTS
TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020–MAY 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY)
TABLE 125 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): BUSINESS OVERVIEW
FIGURE 28 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): COMPANY SNAPSHOT (2022)
11.1.2 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.)
TABLE 126 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): BUSINESS OVERVIEW
FIGURE 29 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): COMPANY SNAPSHOT (2022)
11.1.3 NELCO WORLDWIDE
TABLE 127 NELCO WORLDWIDE: BUSINESS OVERVIEW
11.1.4 GAVEN INDUSTRIES, INC.
TABLE 128 GAVEN INDUSTRIES, INC.: BUSINESS OVERVIEW
11.1.5 RADIATION PROTECTION PRODUCTS, INC.
TABLE 129 RADIATION PROTECTION PRODUCTS, INC.: BUSINESS OVERVIEW
11.1.6 MARSHIELD (A DIVISION OF MARS METAL CO.)
TABLE 130 MARSHIELD (A DIVISION OF MARS METAL CO.): BUSINESS OVERVIEW
11.1.7 RAY-BAR ENGINEERING CORP.
TABLE 131 RAY-BAR ENGINEERING CORP.: BUSINESS OVERVIEW
11.1.8 AMRAY MEDICAL
TABLE 132 AMRAY MEDICAL: BUSINESS OVERVIEW
11.1.9 A&L SHIELDING
TABLE 133 A&L SHIELDING: BUSINESS OVERVIEW
11.1.10 GLOBAL PARTNERS IN SHIELDING, INC.
TABLE 134 GLOBAL PARTNERS IN SHIELDING, INC.: BUSINESS OVERVIEW
11.1.11 VERITAS MEDICAL SOLUTIONS LLC
TABLE 135 VERITAS MEDICAL SOLUTIONS, LLC: BUSINESS OVERVIEW
11.1.12 ALIMED, INC.
TABLE 136 ALIMED, INC.: BUSINESS OVERVIEW
11.1.13 PROTECH MEDICAL
TABLE 137 PROTECH MEDICAL: BUSINESS OVERVIEW
11.1.14 GLOBE COMPOSITE SOLUTIONS LLC
TABLE 138 GLOBE COMPOSITE SOLUTIONS LLC: BUSINESS OVERVIEW
11.1.15 ULTRARAY
TABLE 139 ULTRARAY: BUSINESS OVERVIEW
11.1.16 MARS METAL COMPANY
TABLE 140 MARS METAL COMPANY: BUSINESS OVERVIEW
11.1.17 NUCLEAR LEAD CO.
TABLE 141 NUCLEAR LEAD CO.: BUSINESS OVERVIEW
11.1.18 NUCLEAR SHIELDS B.V.
TABLE 142 NUCLEAR SHIELDS B.V.: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 SHIELDING INTERNATIONAL INC.
11.2.2 BAR-RAY PRODUCTS, INC.
11.2.3 XENA SHIELD
11.2.4 BURLINGTON MEDICAL
11.2.5 SIMAD SRL
11.2.6 EUROPEAN EMC PRODUCTS
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
